Skip to main content
logo
Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.010
+0.050 (2.55%)
Jun 4, 2026, 4:00 PM EDT - Market closed

Protalix BioTherapeutics Revenue

Protalix BioTherapeutics had revenue of $33.75M in the quarter ending March 31, 2026, with 233.73% growth. This brings the company's revenue in the last twelve months to $76.38M, up 27.80% year-over-year. In the year 2025, Protalix BioTherapeutics had annual revenue of $52.74M, down -1.23%.

Revenue (ttm)
$76.38M
Revenue Growth
+27.80%
P/S Ratio
2.12
Revenue / Employee
$337,969
Employees
226
Market Cap
161.95M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202552.74M-655.00K-1.23%
Dec 31, 202453.40M-12.10M-18.47%
Dec 31, 202365.49M17.86M37.48%
Dec 31, 202247.64M9.29M24.22%
Dec 31, 202138.35M-24.55M-39.03%
Dec 31, 202062.90M8.21M15.00%
Dec 31, 201954.69M20.45M59.73%
Dec 31, 201834.24M13.16M62.44%
Dec 31, 201721.08M--
Dec 31, 2016---
Dec 31, 20154.36M841.00K23.87%
Dec 31, 20143.52M--
Dec 31, 20130--
Dec 31, 201234.87M26.48M315.81%
Dec 31, 20118.39M1.74M26.26%
Dec 31, 20106.64M6.25M1,611.86%
Dec 31, 2009388.00K--
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005150.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Heron Therapeutics150.71M
Spero Therapeutics61.19M
MediWound14.48M
Innate Pharma10.57M
NRx Pharmaceuticals2.29M
Oramed Pharmaceuticals2.00M
Revenue Rankings

PLX News

More News